Effects of Particle Geometry for PLGA-Based Nanoparticles: Preparation and In Vitro/In Vivo Evaluation

The physicochemical properties (size, shape, zeta potential, porosity, elasticity, etc.) of nanocarriers influence their biological behavior directly, which may result in alterations of the therapeutic outcome. Understanding the effect of shape on the cellular interaction and biodistribution of intravenously injected particles could have fundamental importance for the rational design of drug delivery systems. In the present study, spherical, rod and elliptical disk-shaped PLGA nanoparticles were developed for examining systematically their behavior in vitro and in vivo. An important finding is that the release of the encapsulated human serum albumin (HSA) was significantly higher in spherical particles compared to rod and elliptical disks, indicating that the shape can make a difference. Safety studies showed that the toxicity of PLGA nanoparticles is not shape dependent in the studied concentration range. This study has pioneering findings on comparing spherical, rod and elliptical disk-shaped PLGA nanoparticles in terms of particle size, particle size distribution, colloidal stability, morphology, drug encapsulation, drug release, safety of nanoparticles, cellular uptake and biodistribution. Nude mice bearing non-small cell lung cancer were treated with 3 differently shaped nanoparticles, and the accumulation of nanoparticles in tumor tissue and other organs was not statistically different (p > 0.05). It was found that PLGA nanoparticles with 1.00, 4.0 ± 0.5, 7.5 ± 0.5 aspect ratios did not differ on total tumor accumulation in non-small cell lung cancer.

[1]  S. Sahin,et al.  Evaluation of Pharmacokinetics and Biodistribution of Targeted Nanoparticles , 2021, Drug Delivery with Targeted Nanoparticles.

[2]  E. Fazio,et al.  Weibull Modeling of Controlled Drug Release from Ag-PMA Nanosystems , 2021, Polymers.

[3]  Jun Wu The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application , 2021, Journal of personalized medicine.

[4]  John R. Clegg,et al.  Non-spherical micro- and nanoparticles for drug delivery: Progress over 15 years. , 2021, Advanced drug delivery reviews.

[5]  Teri W. Odom,et al.  Nanoparticle Shape Determines Dynamics of Targeting Nanoconstructs on Cell Membranes. , 2021, Journal of the American Chemical Society.

[6]  J. M. Benito,et al.  Therapeutic Efficacy and Biodistribution of Paclitaxel-Bound Amphiphilic Cyclodextrin Nanoparticles: Analyses in 3D Tumor Culture and Tumor-Bearing Animals In Vivo , 2021, Nanomaterials.

[7]  Yimeng Du,et al.  Size, shape, charge and “stealthy” surface: Carrier properties affect the drug circulation time in vivo , 2020, Asian journal of pharmaceutical sciences.

[8]  S. Sacanna,et al.  Modulation of Immune Responses by Particle Size and Shape , 2021, Frontiers in Immunology.

[9]  K. Kataoka,et al.  Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation. , 2020, Journal of the American Chemical Society.

[10]  Nicholas A. Peppas,et al.  Engineering precision nanoparticles for drug delivery , 2020, Nature reviews. Drug discovery.

[11]  Jeong-Sook Park,et al.  Design and evaluation of the anticancer activity of paclitaxel-loaded anisotropic-poly(lactic-co-glycolic acid) nanoparticles with PEGylated chitosan surface modifications. , 2020, International journal of biological macromolecules.

[12]  J. Haycock,et al.  UV-Casting on Methacrylated PCL for the Production of a Peripheral Nerve Implant Containing an Array of Porous Aligned Microchannels , 2020, Polymers.

[13]  R. Tekade,et al.  Cancer-targeted chemotherapy: Emerging role of the folate anchored dendrimer as drug delivery nanocarrier , 2020 .

[14]  R. Geertsma,et al.  In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices , 2020, Biocompatibility and Performance of Medical Devices.

[15]  Katharina Gaus,et al.  The impact of nanoparticle shape on cellular internalisation and transport: what do the different analysis methods tell us? , 2019, Materials Horizons.

[16]  S. Mitragotri,et al.  Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[17]  G. Winter,et al.  Nonspherical Nanoparticle Shape Stability Is Affected by Complex Manufacturing Aspects: Its Implications for Drug Delivery and Targeting , 2019, Advanced healthcare materials.

[18]  R. Haag,et al.  Dendritic Polyglycerol-Derived Nano-Architectures as Delivery Platforms of Gemcitabine for Pancreatic Cancer. , 2019, Macromolecular bioscience.

[19]  Jin-Wook Yoo,et al.  Development of PLGA micro- and nanorods with high capacity of surface ligand conjugation for enhanced targeted delivery , 2018, Asian journal of pharmaceutical sciences.

[20]  B. Amini,et al.  Enhanced antibacterial activity of imipenem immobilized on surface of spherical and rod gold nanoparticles , 2018, Journal of Physics D: Applied Physics.

[21]  N. Annabi,et al.  Targeting antigen-presenting cells by anti-PD-1 nanoparticles augments antitumor immunity. , 2018, JCI insight.

[22]  Samir Mitragotri,et al.  Influence of particle size and shape on their margination and wall-adhesion: implications in drug delivery vehicle design across nano-to-micro scale. , 2018, Nanoscale.

[23]  M. R. Mozafari,et al.  Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems , 2018, Pharmaceutics.

[24]  A. Misra,et al.  Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells , 2018, Journal of microencapsulation.

[25]  Chenming Zhang,et al.  Tuning the Size of Poly(lactic‐co‐glycolic Acid) (PLGA) Nanoparticles Fabricated by Nanoprecipitation , 2018, Biotechnology journal.

[26]  Mingshi Yang,et al.  Engineering of budesonide‐loaded lipid‐polymer hybrid nanoparticles using a quality‐by‐design approach , 2017, International journal of pharmaceutics.

[27]  Anil B. Jindal,et al.  The effect of particle shape on cellular interaction and drug delivery applications of micro- and nanoparticles. , 2017, International journal of pharmaceutics.

[28]  Amitav Sanyal,et al.  Influence of Size and Shape on the Biodistribution of Nanoparticles Prepared by Polymerization-Induced Self-Assembly. , 2017, Biomacromolecules.

[29]  A. Middelberg,et al.  Fundamental studies on throughput capacities of hydrodynamic flow-focusing microfluidics for producing monodisperse polymer nanoparticles , 2017 .

[30]  Quan Li,et al.  Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells , 2017, Scientific Reports.

[31]  Qinfu Zhao,et al.  A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics , 2017, Scientific Reports.

[32]  G. Esendagli,et al.  Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers. , 2017, International journal of pharmaceutics.

[33]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[34]  Jordan J. Green,et al.  An automated multidimensional thin film stretching device for the generation of anisotropic polymeric micro- and nanoparticles. , 2015, Journal of biomedical materials research. Part A.

[35]  Roman Mathaes,et al.  Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications , 2015, Expert opinion on drug delivery.

[36]  Sara A Abouelmagd,et al.  Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right? , 2015, Molecular pharmaceutics.

[37]  T. P. Davis,et al.  The importance of nanoparticle shape in cancer drug delivery , 2015, Expert opinion on drug delivery.

[38]  Susan D'Souza A Review of In Vitro Drug Release Test Methods for Nano-Sized Dosage Forms , 2014 .

[39]  Ute Husemann,et al.  Verification of a New Biocompatible Single-Use Film Formulation with Optimized Additive Content for Multiple Bioprocess Applications , 2014, Biotechnology progress.

[40]  Efstathios Karathanasis,et al.  Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. , 2014, Nanomedicine.

[41]  William H Fissell,et al.  What is nanotechnology? , 2013, Advances in chronic kidney disease.

[42]  Emanuel Fleige,et al.  Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. , 2012, Advanced drug delivery reviews.

[43]  Antony Thomas,et al.  The shape of things to come: importance of design in nanotechnology for drug delivery. , 2012, Therapeutic delivery.

[44]  S. McNeil Characterization of Nanoparticles Intended for Drug Delivery , 2011, Methods in Molecular Biology.

[45]  J. Tóth,et al.  Optimization of protein encapsulation in PLGA nanoparticles , 2011 .

[46]  Vladimir Torchilin,et al.  Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.

[47]  A. Patri,et al.  Zeta potential measurement. , 2011, Methods in molecular biology.

[48]  Ying Liu,et al.  Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. , 2010, Biomaterials.

[49]  Asgar Ali,et al.  Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[50]  Claire M. Cobley,et al.  Quantifying the cellular uptake of antibody-conjugated Au nanocages by two-photon microscopy and inductively coupled plasma mass spectrometry. , 2010, ACS nano.

[51]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[52]  S. Mitragotri,et al.  Making polymeric micro- and nanoparticles of complex shapes , 2007, Proceedings of the National Academy of Sciences.

[53]  M. J. Santander-Ortega,et al.  Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. , 2006, Journal of colloid and interface science.

[54]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Joseph M DeSimone,et al.  Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.

[56]  G. Whitesides,et al.  Generation of monodisperse particles by using microfluidics: control over size, shape, and composition. , 2005, Angewandte Chemie.

[57]  Y Li,et al.  PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[58]  A. Keller,et al.  Preparation of monodisperse ellipsoidal polystyrene particles , 1993 .